(Q42689280)

English

Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity

scientific article published on 6 March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity (English)

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Craig W. Lindsley

7

object named as

Craig W Lindsley

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

author name string

Robert Lavieri

1

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Sarah A Scott

2

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Jana A Lewis

3

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Paige E Selvy

4

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Michelle D Armstrong

5

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

H Alex Brown

6

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

language of work or name

0 references

publication date

6 March 2009

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Bioorganic & Medicinal Chemistry Letters

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

19

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

8

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

2240-2243

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800051

27 May 2018

Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800051

27 May 2018

Allosteric modulation of kinases and GPCRs: design principles and structural diversity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800051

27 May 2018

Application of combinatorial chemistry science on modern drug discovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800051

27 May 2018

Requirement of phospholipase D1 activity in H-RasV12-induced transformation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800051

27 May 2018

Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800051

27 May 2018

Development of a custom high-throughput preparative liquid chromatography/mass spectrometer platform for the preparative purification and analytical analysis of compound libraries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800051

27 May 2018

A novel family of phospholipase D homologues that includes phospholipid synthases and putative endonucleases: identification of duplicated repeats and potential active site residues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800051

27 May 2018

Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800051

16 August 2018

Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800051

16 August 2018

Overexpression of phospholipase D1 in human breast cancer tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/19299128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimization of halopemide for phospholipase D2 inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/19299128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased phospholipase D activity in human breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19299128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phospholipase D activity in human gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19299128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased activity and intranuclear expression of phospholipase D2 in human renal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19299128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BMCL.2009.02.125

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42689280&oldid=1965588707"